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We have recently shown that two antimicrobial peptides (BacS and Bac7) and/or their immature forms (proBac5 and proBac7) can be released 
extracellularly from activated neutrophils. In the present study we have investigated the biological activities of the immature forms, which do not 
exhibit antimicrobial effects. We show that proBac7 is a monocyte-selective chemoattractant, potentially contributing to the recruitment of these 
cells to infection sites, whereas proBac5 efficiently inhibits the in vitro activity of cathepsin L. a cysteine proteinase thought to contribute to tissue 
injury in inflammation. 
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1. INTRODUCTION proBac5 was tested for its potential inhibitory effect on 
such a cysteine proteinase. 
Neutrophils are the primary effector cells in acute 
inflammation. They are rapidly recruited from the 
blood stream by adhesion to, and migration through, 
the vascular endothelium, and chemotaxis to injured or 
infected tissue. The various stages of this complex proc- 
ess are accompanied by the release of specific factors, 
which are instrumental to transendothelial migration, 
amplification of the inflammatory and immune re- 
sponses, and defense reactions [l-5]. 
2. MATERIALS AND METHODS 
2.1. Purification of Bad and Bac7 and their precursors 
In recent years we have characterized a variety of 
antimicrobial peptides of bovine neutrophils [6-l 11. 
These include two proline- and arginine-rich peptides, 
bactenecins or Bac5 and Bac7, which are stored in the 
large granules as precursors [9]. Activation of neutro- 
phils causes the release of bactenecins and/or their pro- 
forms [lo]. Since proBac5 and proBac7 are devoid of 
any antimicrobial activity [9,11], we thought they might 
perform other bioactivities unrelated to pathogen inac- 
tivation. In particular, since the initial wave of neutro- 
phils, typical of the inflammatory response, is rapidly 
followed by a second wave of monocytes, we checked 
whether they might become engaged in monocyte re- 
cruitment. Second, since the pro-region of Bac5 has a 
high identity with a specific inhibitor of cathepsin L [12], 
BacS and Bac7 were purified from granule extracts (200 mM sodium 
acetate, pH 5) of bovine blood neutrophils as previously described [7]. 
To purify their precursors, the granular extracts were applied to a 
CM-cellulose column (CM-52, Whatman Inc., Maidstone, Kent, UK) 
equilibrated with the extraction buffer. The column was eluted with 
0.1, 0.2, 0.3 and 1 M NaCl in the same buffer, and the fractions 
collected were dialysed against 0.1% TFA. Those containing proBac5 
or proBac7, as identified by Western blot analysis, were vacuum con- 
centrated, re-dissolved in 0.1% TFA, and then loaded on a Pep RPC 
lO/lO column (Pharmacia LKB Biotechnology, Uppsala, Sweden). 
Elution was performed with a O-1008 acetonitrile gradient in 0.1% 
TFA, and fractions corresponding to proBac5 or proBac7 were 
pooled, lyophilised, and either diluted in PBS (pH 7.4)/ 0.5 mM Ca2’/ 
1% BSA for assays of chemotactic activity, or dissolved in distilled 
water for protease inhibition studies. 
2.2. Analytical assays 
Protein concentration was measured with bicinchoninic acid (Pierce 
Chemical Co., Rockford, IL) using BSA as the standard. SDS-PAGE 
was carried out under reducing conditions in 14% polyacrylamide gel, 
and Western blots were performed as in [9]. 
2.3. Monocyre preparation and chemotaxis assay 
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marin; PMA, phorbol 12-mirystate 13-acetate. 
Monocytes were prepared from the interface buffy coat, generated 
after differential centrifugation (2 000 x g, 20 min) of bovine blood. 
After lysing the erythrocytes, the mononuclear cells were centrifuged 
at 700 x g for 20 min at 4°C through a Ficoll-Paque gradient (Pharma- 
cia LKB Biotechnology). The final preparations contained 6&70% 
monocytes and 3&40% lymphocytes, as determined by non-specific 
esterase assay [13]. Migration of monocytes was evaluated in a mul- 
tiwell chamber (Neuro Probe Inc., Cabin John, MD) [14]. A 5-pm pore 
size polycarbonate filter (Nucleopore Corp., Pleasanton, CA) was 
used to separate the upper wells containing 0.75 x lo5 monocytes in 
50 ml of PBS/O.5 mM Ca*‘/l% BSA from the lower wells. which 
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contained the putative chemotactic factors in 50.~1 of the same buffer. 
Neutrophil chemotaxis was performed with 8 pm polyvinylpir- 
rolidone-free polycarbonate filters Nucleopore). Negative- and POW 
tive controls were run with dilution buffer and 5% zymosan-activated 
bovine serum, respectively. Experiments were carried out m quadru- 
plicate with lo-‘~10~” M proBac7, Bac7, proBac5 or Bac5. After 90 
mm at 37°C m air with 5% C02, the filters were carefully removed and 
stained with Diff-Quick (Harleco, Gbbstown, NJ). Five oil immersion 
fields were counted, and the activity was expressed as percentage of 
cells migrated over negative controls. 
2.4. Enzyme assays 
Human kidney cathepsin L (Calbiochem, CO), human liver cathep- 
sin B (Novabiochem, CO) were assayed with Z-Phe-Arg-AMC. and 
Z-Arg-Arg-AMC, respectively [15]. The fluorescence intensity (a,, 370 
nm, I,,,, 460 nm) of the released aminomethylcoumarin was recorded 
continuously for 15-20 min. Papain (Sigma, St. Louis, MO) was as- 
sayed with BANA (Sigma) as substrate [16]. For the determination of 
the inhibition constant, 0.1 nM cathepsin L was incubated 30 min at 
37°C with 20-500 nM proBac 5 before adding 5. 10. 20 PM Z-Phe- 
Arg-AMC (final concentrations). The reaction was stopped after 10 
min with 2 ml of 1 mM iodoacetic acid. Fluorescence intensity was 
measured as above. and the K, was calculated by the EisenthalKor- 
nish Bowden and the Bieth and Dixon plots. 
3. RESULTS AND DISCUSSION 
3.1. Chemotactic activity 
Previous experiments [lo] showed that over 50% of 
the proBac5 and proBac7 content of neutrophil gran- 
ules can be released into the extracellular medium upon 
cell exposure to PMA, commonly used as a secre- 
tagogue for neutrophils. This finding thus indicates that 
neutrophils may respond to some stimuli by delivering 
proBac5 and proBac7 to extracellular targets. Based on 
the observation that neutrophil recruitment o inflam- 
mation sites precedes a large mobilization of mon- 
ocytes, we examined whether the released antibiotic pre- 
cursors may contribute to the generation of chemotactic 
signals for monocytes .
The chemotactic activity was tested using the modi- 
fied Boyden chamber technique, with various concen- 
trations of the putative chemoattractants. Fig. 1 shows 
that proBac7 displays a chemoattractant activity which 
peaks at 10m9 M. At this concentration the activity of 
proBac7 is about one third of that exerted by activated 
serum (624 + 53). The chemoattractant activity of the 
antibiotic peptide Bac7, generated by proteolytic matu- 
ration of proBac7, is much lower (Fig. l), and does not 
follow the bell-shaped curve typical of chemotactic fac- 
tors. ProBac5 and Bac5 in the same concentration range 
do not cause monocyte chemotaxis (not shown). Fi- 
nally, at the concentrations tested, all these peptides 
practically do not induce any activation of random or 
oriented neutrophil migration (not shown). 
The monocyte-selective chemotactic activity exhib- 
ited by proBac7 suggests that this peptide may be one 
of the factors released by bovine neutrophils to amplify 
the inflammatory response. Although the observed che- 
moattraction is not as marked as that exhibited by com- 
plement fragments present in zymosan-activated serum, 
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Fig. 1. Chemotactic response of bovine monocytes to proBac7 (0) and 
Bac7 (n). Migration of monocytes was evaluated by using a multiwell 
microchamber technique. Relative chemotacic activities are 
means + S.E.M. of 5-12 cell preparations, and were calculated as a 
percentage of migrated cells over negative controls 
the contribution of proBac7 to the generation of chemo- 
tactic signals is nevertheless likely to be significant. In 
fact, a gradual release of this polypeptide from neutro- 
phils in the inflammatory site, coupled to its relative 
stability [lo], would secure cumulative and persistent 
effects in monocyte chemoattraction. 
The chemotactic activity of proBac7 appears to be 
confined to the pro-region of the molecule, since its 
maturation product Bac7, endowed with antibiotic ac- 
tivity, has little or no effect on the migration of mon- 
ocytes. Conversely, other neutrophil antimicrobial pep- 
tides, such as human defensins and CAP37, are good 
monocyte-selective chemoattractants [17-l 81. 
3.2. Inhibition of cathepsin L byproBac5 
Molecular cloning of Bac5 has shown that the region 
upstream of the antibiotic peptide (pro-sequence) shares 
about 70% identity with cathelin [ 121, an inhibitor of the 
lysosomal cysteine proteinase, cathepsin L, isolated 
from pig leukocytes [19]. Cathepsin L is present in in- 
flammatory cells [20], and may contribute substantially 
to tissue injury at inflammatory lesions, due to its po- 
tent elastinolytic and collagenolytic activities [21,22]. 
ProBac5 purified from bovine neutrophils was there- 
fore tested for its potential inhibitory activity on this 
enzyme as well as on other cysteine proteinases. 
The hydrolytic activity of cathepsin L on the syn- 
thetic substrate Z-Phe-Arg-AMC is inhibited by 80% 
within a few minutes after the addition of 10e6 M pro- 
Bac5 (Fig. 2A). Parallel control experiments how that 
lo-’ M leupeptin exerts full inhibition of this proteinase. 
The inhibition constant for the interaction of proBac5 
with cathepsin L is 6 x lo-*M. Since the proteolytic 
fragment Bac5 has virtually no effect on the activity of 
cathepsin L (Fig. 2A), the inhibitory effect appears to 
be mediated by the pro-sequence of the precursor, as 
expected [121. 
Volume 3 17, number 3 FEBSLETTERS February 1993 
I 
5 10 15 min 
GE 
I 





m / 0 
_ 
Z Ii/, 
5 10 15 min 
Fig. 2. Effect of proBac5 and Bac5 on the activity of cysteine pro- 
teinases. (A) Cleavage of the fluorogenic substrate Z-Phe-Arg-AMC 
by cathepsin L (2.5 ng) alone (a), and in the presence of either 10m6 
M Bac5 (h) or 10m6 M proBac5 (c) or lo-’ M leupeptin (d). Fluores- 
cence measurements were made at a concentration of cathepsin L 
corresponding to the hydrolysis of 33.75 pmol substrate/min. (B) 
Cleavage of the fluorogenic substrate Z-Arg-Arg-AMC by cathepsin 
B (20 ng) alone (a), and in the presence of either 10m6 M proBac5 (b) 
or lo-’ M leupeptin (c). Fluorescence measurements were made at a 
concentration of cathepsin B corresponding to the hydrolysis of 240 
pmol substrate/min. (C) Cleavage of the fluorogenic substrate BANA 
by papain (10 mg) alone (a), and in the presence of 10m6 M proBac5 
@) or lo-’ M leupeptin (c). Fluorescence measurements were made at 
a concentration of papain corresponding to the hydrolysis of 207 nmol 
substrate/min. Arrows indicate the addition of proBac5 or Bac5 or 
leupeptin. 
Cathepsin L appears to be a specific target for this 
inhibitor, since other cysteine proteinases, such as 
cathepsin B (Fig. 2B) and papain (Fig. 2C) are unaf- 
fected by proBac5, while completely inhibited by le- 
upeptin. 
Due to its elastinolytic and collagenolytic activities 
[21,22], cathepsin L is a major factor in tissue degrada- 
tion. In particular, it can degrade glomerular basement 
membrane [23] and cause bone resorption [24]. Inhibi- 
tion of this proteinase by a polypetide released in rela- 
tively large amounts from neutrophils at inflammatory 
sites might thus be of great significance in prevention of 
tissue damage. 
Overall, our results emphasize the marked efficiency 
of cell-dependent innate immunity. Polypeptides se- 
creted from neutrophils appear to be structured to re- 
spond to different functional requirements, including 
amplification of the response, host defense, and tissue 
protection from inflammatory damage, while in some 
cases combining more than one such activity within the 
same molecule. 
Acknowledgements: D.V. acknowledges the award of a FEBS fellow- 
ship. This work was supported by grants from the Consigho Nazionale 
delle Ricerche (Progetto Finahzzato ‘Biotecnologie Biostrumentazi- 
one’) and from the Minister0 dell’Universit&agrave;  della Ricerca. 
REFERENCES 
[l] Henson, P.M. and Johnston, R.B. (1987) J. Clin. Invest. 79, 
669-674. 
[2] Clark, R.A. (1990) J. Infect. Dis. 161, 1140-l 147. 
[3] Lehrer, RI. and Ganz, T. (1990) Blood 76,2169-2181. 
[4] Gennaro, R., Romeo, D. Skerlavaj, B. and Zanetti, M. (1991) in: 
Blood Cell Biochemistry, vol. 3 (Harris, J.R., ed.) pp. 335-368, 
Plenum, New York. 
[5] Lloyd, A. R. and Oppenheimer, J. J. (1992) Immunol. Today 13, 
169-171. 
[6] Romeo, D., Skerlavaj, B., Bolognesi, B. and Gennaro, R. (1988) 
J. Biol. Chem. 263, 9573-9575. 
[7] Gennaro, R., Skerlavaj, B. and Romeo, D. (1989) Infect. Immun. 
57, 3142-3146. 
[8] Skerlavaj, B., Romeo, D. and Gennaro, R. (1990) Infect. Immun. 
58, 37243730. 
[9] Zanetti, M., Litten, L., Gennaro, R., Horstmann, H. and Romeo, 
D. (1990) J. Cell Biol. 111, 136331371. 
[lo] Zanetti, M., Litteri, L., Griffiths, G., Gennaro, R. and Romeo, 
D. (1991) J. Immunol. 146, 42954300. 
[l I] Scocchi, M., Skerlavaj, B., Romeo, D. and Gennaro, R. (1992) 
Eur. J. Biochem. 209, 589-595. 
[12] Zanetti, M., Del Sal, G., Storici, P., Schneider, C. and Romeo, 
D. (1993) J. Biol. Chem. (in press). 
[13] Koski, I.R., Poplack, D.G. and Blaese, R.M. (1976) in: In Vitro 
Methods in Cell-Mediated and Tumor Immunity (Bloom, B.R. 
and David, J.R., eds.) pp. 359-362, Academic Press, New York. 
[14] Falk, W., Goodwin, R.H. and Leonard. E.J. (1980) J. Immunol. 
Methods 33, 2399247. 
[15] Barrett, A.J. and Kirschke, H. (1981) Methods Enzymol. 80, 
535-562. 
[16] Amon, R. (1970) Methods Enzymol. 19, 226-244. 
[I 71 Territo, M.C., Ganz, T., Selsted, M.E. and Lehrer, R. (1989) J. 
Clin Invest. 84, 2017-2020. 
[18] Pereira, H.A., Shafer, W.M., Pohl, J., Martin, L.E. and Spitz- 
nagel, J.K. (1990) J. Clin. Invest. 85, 1468-1476. 
257 
Volume 317, number 3 FEB.5 LETTERS February 1993 
[19] Kopitar, M., Ritonja, A., Popovic, T., Gabrijelcic, D., Krizaj, I. 
and Turk, V. (1989) Biol. Chem. Hoppe-Seyler 370, 1145-1151. 
[20] Bando, Y., Kominami, E. and Katunuma, N. (1986), J. Biochem. 
100, 3542 
[21] Mason, R. W., Johnson, D. A., Barrett, A. J. and Chapman, H. 
A. (1986) Biochem. J., 233, 925-927. 
[22] Kirschke, H. and Barrett, A. J. (1987) in: Lysosomes: Their Role 
in Protein Breakdown (Glaumann, H. and Ballard, F. J. eds.) pp. 
193-238. Academic Press, New York. 
[23] Baricos, W. H., Zhou, Y., Mason, R. W. and Barrett, A. J. (1988) 
Biochem. J. 252, 301-304. 
[24] Rifkin, B. R., Vernillo, A. T., Kleckner, A. P., Auszmann, J. M., 
Rosenberg, L. R. and Zimmerman, M. (1991) Biochem. Biophys. 
Res. Commun. 179, 63-69. 
258 
